Main Article Content
Alzheimer’s disease is a complex, progressive, neurodegenerative disorder with a multifactorial etiology. More than one mechanism appears to be involved in its pathogenesis. Current treatment targeting only a single mechanism provides only symptomatic relief and is unable to stop the progression of the disease. There is a substantial unmet medical need to develop more efficacious drugs that can address all the causative factors that lead to the development and progression of Alzheimer’s disease. One of the strategies which has emerged is the development of chimeric conjugate compounds, in which multiple bioactive components are combined to form novel molecular entities, that can simultaneously regulate multiple mechanisms effectively. This chapter presents an overview of the various factors contributing to the pathophysiology of Alzheimer’s disease. Chimeric strategies that are being developed to supplement the single-mechanism targeting acetylcholinesterase drugs, which are currently available for the treatment of Alzheimer’s disease, are also exemplified.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.